ARCHIVES

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved Last Month By NCI’s CTEP

May 31, 2002

Funding Opportunity: DOD Offering 10.5 Million For Lung Cancer Research

May 30, 2014

NCI Plans $40M In Grants For Cancer Outcomes Studies.

June 30, 2000

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974

Congress Renews National Cancer Act, Including Most Key Amendments Sought By NCI And Allied

October 28, 1988

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002